Related references
Note: Only part of the references are listed.Are there protective treatments for cognitive decline in MS?
MP Amato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Effects of donepezil on memory and cognition in multiple sclerosis
Christopher Christodoulou et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Evidence-based pharmacotherapy of Alzheimer's disease
JG Evans et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Donepezil improved memory in multiple sclerosis in a randomized clinical trial
LB Krupp et al.
NEUROLOGY (2004)
Cognitive dysfunction in multiple sclerosis: a review of recent developments
JA Bobholz et al.
CURRENT OPINION IN NEUROLOGY (2003)
Fatigue associated with multiple sclerosis: diagnosis, impact and management
R Bakshi
MULTIPLE SCLEROSIS JOURNAL (2003)
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months
T Darreh-Shori et al.
NEUROLOGY (2002)
Motor vehicle crashes and violations among drivers with multiple sclerosis
MT Schultheis et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2002)
Effect of interferon-beta-1b on cognitive functions in multiple sclerosis
Y Barak et al.
EUROPEAN NEUROLOGY (2002)
Cognitive dysfunction in early-onset multiple sclerosis - A reappraisal after 10 years
MP Amato et al.
ARCHIVES OF NEUROLOGY (2001)
The influence of cognitive impairment on driving performance in multiple sclerosis
MT Schultheis et al.
NEUROLOGY (2001)
A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments
YM Greene et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Share Paper
